Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gametogenetin (GGN) is a protein encoded by the GGN gene, mainly expressed in testicular germ cells, where it is thought to play an essential role in spermatogenesis and male fertility[1][2]. Alternative splicing of GGN gives rise to at least three protein isoforms: GGN1, GGN2, and GGN3, which differ in their cellular localization and interaction partners[1][2]. GGN is not present at significant levels in other tissues. It is believed to interact with proteins such as Fanconi anemia complementation group L (FANCL) and gametogenetin binding protein 1 (GGNBP1), influencing processes including germ cell proliferation and intracellular membrane trafficking[1]. Disruption of GGN function has been associated with male infertility disorders such as spermatogenic failure and globozoospermia[2][3]. No therapeutic agents are known to target gametogenetin, and it is not considered a classical drug target, but rather a protein relevant to reproductive biology and germ cell physiology[1][2][3].
Not applicable; no drugs known to target gametogenetin
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gametogenetin (GGN).